Vericiguat in patients with heart failure across the spectrum of left ventricular ejection fraction: a patient-level, pooled meta-analysis of VITALITY-HFpEF and VICTORIA
C Chen, J Lv, C Liu - Frontiers in Endocrinology, 2024 - frontiersin.org
Vericiguat, the newest soluble guanylate cyclase (sGC) drug, is potentially beneficial in
treating heart failure (HF). However, most studies have only confirmed the significant impact …
treating heart failure (HF). However, most studies have only confirmed the significant impact …